Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Group Llc Column currently holds 1,352,008 shares of RAPT Therapeutics, Inc. (RAPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Group Llc Column has been a net buyer of RAPT stock. They have purchased $13.3M and sold $2.4M worth of shares.
Group Llc Column's most recent insider trade was on Dec 23, 2024, when they sold 1,352,008 shares at $0.00 per share.
Group Llc Column serves as Executive at RAPT Therapeutics, Inc. (RAPT). They have executed 10 insider transactions totaling $15.8M over their tenure at the company.
Group Llc Column holds the position of Executive at RAPT Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Group Llc Column has shown a buying trading pattern, with $13.3M in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Group Llc Column was on May 10, 2022, when they purchased $12.9M worth of RAPT shares. This transaction involved 1,208,750 shares at $10.67 per share.
Group Llc Column currently owns 1,352,008 shares of RAPT Therapeutics, Inc. (RAPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Group Llc Column's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Group Llc Column has 10 Form 4 filings on record as an insider at RAPT Therapeutics, Inc..
Set alerts for Group Llc Column and 40,000+ other insiders.